Listen Live

Current Weather

Loading advertisement…

Lilly, Novo lock horns in India’s obesity drug race

HYDERABAD, India, Dec 24 (Reuters) - Global pharma giants Eli Lilly and Novo Nordisk are scrambling to cement their lead in India's booming obesity drug market before cheaper generic versions hit shelves in March next year. Novo's strategy emphasizes price cuts and accelerated launches, while... Read More.